The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood–brain barrier

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Alfred H. Schinkel, Els Wagenaar, Carla A.A.M. Mol et al. · Journal of Clinical Investigation · 1996 · 1.3K citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacology. Principles and Practice

Joseph G. Cannon · Journal of Medicinal Chemistry · 2010 · 97 citations

Medicine, Medicinal Chemistry, Pharmacology +6

¹¹C-Loperamide and Its<i>N</i>-<i>Desmethyl</i>Radiometabolite Are Avid Substrates for Brain Permeability-Glycoprotein Efflux

Sami S. Zoghbi, Jeih‐San Liow, Fumihiko Yasuno et al. · Journal of Nuclear Medicine · 2008 · 86 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +15

Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice

Heleen A. Bardelmeijer, Mariët Ouwehand, Jos H. Beijnen et al. · Investigational New Drugs · 2004 · 80 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor

Florian F. Bauer, Claudia Kuntner, Jens P. Bankstahl et al. · Bioorganic & Medicinal Chemistry · 2010 · 78 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16